Performance
Trailing returns
| 1 day | +0.38% |
| |||
| 1 week | +2.83% |
| |||
| 4 week | +11.02% |
| |||
| 3 month | +17.65% |
| |||
| YTD | +25.37% |
| |||
| 1 year | +44.65% |
| |||
| 3 years* | +23.40% |
| |||
| 5 years* | - | ||||
| *annualized | |||||
| Best 3 month return | +31.64% | |
| Worst 3 month return | -26.13% |
Morningstar statistics
Morningstar category: Mid-Cap Growth
| Return | Risk | Rating | |
| 3 years | High | High |
 
|
| 5 years | - | - | - |
| 10 years | - | - | - |
| Overall | High | High |
|
Morningstar style Learn more
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
Key statistics
| Total assets | 51.94M | |
| Front load | - | |
| Deferred load | - | |
| Expense ratio | 1.63% | |
| Management fee | - | |
| Fund family | Eventide Funds |
Asset allocation
| Cash | 0.00% | |
| Stocks | 96.56% | |
| Bonds | 0.80% | |
| Other | 2.64% |
Purchase information
| Initial | US$1,000 | |
| Additional | US$50 | |
| IRA Initial | US$1,000 | |
| AIP Initial | US$1,000 | |
| AIP Additional | US$100 |
18.19-0.27(-1.46%)
May 22, 4:00PM EDT
Overall Morningstar RatingTM
Description
The investment seeks to provide long-term capital appreciation. Normally, the fund invests primarily in a broad range of equity securities without limitation to market capitalization. It may invest without limitation in securities in companies domiciled outside the United States either directly or through ADRs. From time to time, the fund may invest a substantial portion of its assets in the stock of companies in one or more industries or industry groups of the economy that are typically not highly correlated with the overall market, such as the industry group consisting of biotechnology and pharmaceutical companies.
Fund filings (PDF) »
Fund filings (PDF) »
Asset managers:
Finny Kuruvilla (Started: Jul 1, 2008)
David Barksdale (Started: Nov 1, 2010)
Finny Kuruvilla (Started: Jul 1, 2008)
David Barksdale (Started: Nov 1, 2010)
Risk
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | 3.60 | -1.01 | - | - | |
| Beta* | 1.06 | 1.32 | - | - | |
| Mean annual return | 1.73 | 1.37 | - | - | |
| R-squared* | 76.09 | 90.45 | - | - | |
| Standard deviation | 12.41 | 20.85 | - | - | |
| Sharpe ratio | 1.66 | 0.78 | - | - | |
| * Against standard index | |||||
Top 10 holdings
| Security | Net Assets | |
| Macquarie Infrastructure Company LLC (MIC) | 3.79% | |
| NPS Pharmaceuticals Inc (NPSP) | 3.33% | |
| Dyax Corporation (DYAX) | 3.04% | |
| Dynavax Technologies Corporation (DVAX) | 3.01% | |
| Ultratech, Inc. (UTEK) | 2.94% | |
| Aspen Technology, Inc. (AZPN) | 2.72% | |
| Wabco Holdings Incorporated (WBC) | 2.65% | |
| SPDR Gold Shares | 2.64% | |
| Tesla Motors, Inc. (TSLA) | 2.63% | |
| Illumina, Inc. (ILMN) | 2.48% |